LogicBio Therapeutics Funding: $50M Raised

LogicBio Therapeutics funding overview

LogicBio Therapeutics is based in Cambridge, MA. LogicBio Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for LogicBio Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund. 5 distinct backers are named across the disclosed rounds.

LogicBio Therapeutics at a glance

Total raised: $50M
Latest round date: June 2017
Headquarters: Cambridge, MA
Notable investors: Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund

Frequently asked about LogicBio Therapeutics funding

How much has LogicBio Therapeutics raised?: LogicBio Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in LogicBio Therapeutics?: Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund are named among the investors backing LogicBio Therapeutics.
What was the latest LogicBio Therapeutics funding round?: No round stage has been disclosed for LogicBio Therapeutics.
Where is LogicBio Therapeutics based?: LogicBio Therapeutics is based in Cambridge, MA.
When did LogicBio Therapeutics last raise?: The last disclosed LogicBio Therapeutics round closed in June 2017.

We update the LogicBio Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.

LogicBio Therapeutics Funding: $50M Raised

LogicBio Therapeutics funding overview

LogicBio Therapeutics at a glance

Frequently asked about LogicBio Therapeutics funding

Companies related to LogicBio Therapeutics (18)

Browse related funding lists (5)